Dr. Jeremy Skillington
Jeremy began is biotechnology career in the Business Development group of Genentech, Inc in 2002. At Genentech he was responsible for executing over 40 licensing, investment and collaboration transactions. He then led Business Development and was a member of the Senior Management team at Opsona Therapeutics before becoming a founder and CEO of immuno-oncology company TriMod Therapeutics. He joined HS Lifesciences in 2014 to provide start-up and business development support to portfolio companies ImmunoQure AG and Ethris GmbH. Jeremy studied Biochemistry at the National University of Ireland, Galway where he was awarded his Ph.D. He performed his post-doctoral research at the University of California, San Francisco in the lab of Prof Rik Derynck.
product development , biotechnology , Business management